Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

A University of Minnesota Medical School research team has found that access to wheelchairs through Medicare-listed suppliers ...

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

Democratic lawmakers have written a letter to the Centers for Medicare and Medicaid Services, criticizing the Trump ...

The Trump administration announced deals with Novo Nordisk and Lilly to sell their weight loss products at a discounted rate ...

Agreements with Eli Lilly and Novo Nordisk firms will lower costs to as little as $149 per month and align Medicaid prices ...